NEWS

Nov 17,2021

Announcement on Soliciting Public Opinions on the Measures for the Administration of the National Essential Drug List (Revised Draft)

In order to further consolidate the national essential drug system and establish and improve the selection and adjustment mechanism of the national essential drug list, the Department of Drug Administration of the National Health Commission organized the study and revision of the measures for the Administration of the National essential Drug list (issued in 2015), and formed the revised draft of the measures for the Administration of the National essential Drug list (see annex). Now for the public to solicit opinions.

Key words:

Announcement on Soliciting Public Opinions on the Measures for the Administration of the National Essential Drug List (Revised Draft)

Apr 11,2022

Opinions of the General Department of the State Food and Drug Administration on Strengthening the Collaborative Supervision of Cross-regional Commissioned Production of Medical Devices

The implementation of the medical device registrant system is an important measure to promote the reform of the medical device review and approval system and strengthen the management of the whole life cycle of medical devices. With the implementation of the regulations on the Supervision and Administration of Medical Devices (decree No. 739 of the State Council), the registrant system has been fully implemented, and the organizational forms of medical device production have become more diverse. in particular, medical device registrants carry out entrusted production across provinces, autonomous regions and municipalities directly under the Central Government (hereinafter referred to as "cross-regional entrusted production"), involving the division of responsibilities and coordination of provincial drug regulatory departments, bringing new challenges to the regulatory work. In order to effectively strengthen the supervision of cross-regional entrusted production by medical device registrants, consolidate the note.

Key words:

Opinions of the General Department of the State Food and Drug Administration on Strengthening the Collaborative Supervision of Cross-regional Commissioned Production of Medical Devices

Apr 11,2022

The General Department of the State Food and Drug Administration publicly solicits opinions on the "Pharmaceutical Business Quality Management Practice-Drug Retail Distribution Quality Management Appendix (Draft for Solicitation of Comments)"

In order to further standardize the behavior of drug retail distribution and ensure the quality and safety of drugs in retail distribution, the State Food and Drug Administration has organized the drafting of the "Pharmaceutical Business quality Management Standard-Drug Retail Distribution quality Management Appendix (draft for soliciting opinions)" (Annex 1). Please fill in the feedback form (Annex 2) and send it back to the e-mail box before March 31, 2022: ypjgs@nmpa.gov.cn. Please indicate "Feedback on Appendix to Drug Retail Distribution Quality Management" in the subject of the e-mail ".

Key words:

The General Department of the State Food and Drug Administration publicly solicits opinions on the "Pharmaceutical Business Quality Management Practice-Drug Retail Distribution Quality Management Appendix (Draft for Solicitation of Comments)"

Apr 11,2022

The latest pharmaceutical O2O market report

Over the past two years, the entire pharmaceutical retail market has been hit by the epidemic, with many categories showing relatively low growth. In 2020 compared to 2019, the overall retail industry will grow at only 3.6 percent, and in the first three quarters of this year compared to the first three quarters of 20 years, the overall growth rate will be only 3 percent.

Key words:

The latest pharmaceutical O2O market report

Apr 18,2022

Drug annual report system officially implemented, the whole network office channel simultaneously opened

In order to implement the relevant requirements of the newly revised Drug Administration Law and the measures for the Supervision and Administration of Drug production, and to establish a scientific and strict drug supervision and management system, on April 12, 2022, the State Food and Drug Administration formally issued the regulations on the Administration of Drug Annual reports. The annual drug report will serve as a reference material and basis for research and judgment for supervision and inspection, risk assessment, and credit supervision. In order to ensure that the new drug annual report system comes into effect, under the guidance and support of the Drug Supervision Department of the State Food and Drug Administration, the Information Center has successfully completed the development and construction of the drug annual report collection module, and will be launched simultaneously on the date of implementation of the system, which can realize online reporting.

Key words:

Drug annual report system officially implemented, the whole network office channel simultaneously opened

Jun 24,2022

The the People's Republic of China Science and Technology Progress Law shall come into force on January 1, 2022.

The Law of the People's Republic of China on the the People's Republic of China of Science and Technology Progress, as amended and adopted at the 32nd Session of the Standing Committee of the 13th National People's Congress of the People's Republic of China on December 24, 2021, is hereby promulgated, and shall come into force on January 1, 2022.

Key words:

The the People's Republic of China Science and Technology Progress Law shall come into force on January 1, 2022.
< 1...58596061 >
Chenglian Medicine

Follow us

Zhejiang Jianfeng Pharmaceutical Co., Ltd.

Sales Line:

+86-579-82131973
Mailbox:gs@zjifyy.com.cn
Company address: No.88, Wujiang East Road, Jinhua City, Zhejiang Province

Copyright©2023 Zhejiang Jianfeng Pharmaceutical Co., Ltd

Powered by www.300.cn | SEO  | Business License

SAF Coolest v1.3.1.1 设置面板XRBSX-ZEJN-JAAZE-ZWD

图片ALT信息： JIANFENG

无数据提示

Sorry, the current column is being updated, please look forward to it!

You can view other columns or returnHome Page